Similar articles for PMID: 34593415

Year	Number of Results
2008	1
2013	1
2015	2
2016	8
2017	7
2018	14
2019	25
2020	36
2021	27
2022	36
2023	14
2024	0

1

Randomized Clinical Trials and Real World Prospective Observational Studies on Bevacizumab, PARP Inhibitors, and Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced Ovarian Carcinoma: A Critical Review.

Gadducci A, Cosio S. Gadducci A, et al. Anticancer Res. 2021 Oct;41(10):4673-4685. doi: 10.21873/anticanres.15281. Anticancer Res. 2021. PMID: 34593415 Review.

2

[Real-world clinical data analysis of PARPi as first-line maintenance therapy in newly diagnosed epithelial ovarian cancer patients].

Wang DF, Zhang J, Zhang C, Yu J, Shi Y, Xu SQ, Fan Y, Zhou FZ, Song SQ, Liu H, Zhang GN. Wang DF, et al. Zhonghua Fu Chan Ke Za Zhi. 2022 Sep 25;57(9):641-652. doi: 10.3760/cma.j.cn112141-20220728-00490. Zhonghua Fu Chan Ke Za Zhi. 2022. PMID: 36177575 Chinese.

3

First-Line Management of Advanced High-Grade Serous Ovarian Cancer.

Mahmood RD, Morgan RD, Edmondson RJ, Clamp AR, Jayson GC. Mahmood RD, et al. Curr Oncol Rep. 2020 Jun 4;22(6):64. doi: 10.1007/s11912-020-00933-8. Curr Oncol Rep. 2020. PMID: 32494876 Free PMC article. Review.

4

Clinical Trials of Novel Targeted Therapies in Ovarian Cancer: Moving Beyond Poly ADP Ribose Polymerase (PARP) Inhibitors.

Guo Q, Yang Q, Li J, Liu G, Nikoulin I, Jia S. Guo Q, et al. Curr Pharm Biotechnol. 2018;19(14):1114-1121. doi: 10.2174/1389201020666181226123054. Curr Pharm Biotechnol. 2018. PMID: 30585545 Review.

5

Traitement médical de première ligne du cancer épithélial de l'ovaire de haut grade: First-line medical treatment of high-grade epithelial ovarian cancer.

Selle F, Alexandre J, Prulhière K, Kalbacher E, Ray-Coquard I, Leary A; pour le groupe GINECO. Selle F, et al. Bull Cancer. 2021 Dec;108(9S1):S5-S12. doi: 10.1016/S0007-4551(21)00582-8. Bull Cancer. 2021. PMID: 34955161 Review.

6

Poly (ADP-ribose) polymerase (PARP) inhibitor regimens for ovarian cancer in phase III randomized controlled trials: a network meta-analysis.

Gong H, Nie D, Huang Y, Li Z. Gong H, et al. Int J Gynecol Cancer. 2020 Oct;30(10):1576-1582. doi: 10.1136/ijgc-2020-001373. Epub 2020 Aug 19. Int J Gynecol Cancer. 2020. PMID: 32817083

7

PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations.

Vanacker H, Harter P, Labidi-Galy SI, Banerjee S, Oaknin A, Lorusso D, Ray-Coquard I. Vanacker H, et al. Cancer Treat Rev. 2021 Sep;99:102255. doi: 10.1016/j.ctrv.2021.102255. Epub 2021 Jul 15. Cancer Treat Rev. 2021. PMID: 34332292 Review.

8

A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial.

Park J, Lim MC, Lee JK, Jeong DH, Kim SI, Choi MC, Kim BG, Lee JY. Park J, et al. J Gynecol Oncol. 2022 Mar;33(2):e12. doi: 10.3802/jgo.2022.33.e12. Epub 2021 Dec 6. J Gynecol Oncol. 2022. PMID: 34910393 Free PMC article. Clinical Trial.

9

Prise en charge médicale de la récidive du cancer épithélial de l'ovaire: Medical management of recurrent epithelial ovarian cancer.

Pautier P, Motte-Rouge T, Lécuru F, Classe JM, Ferron G, Floquet A, Kurtz JE, Freyer G, Hardy-Bessard AC. Pautier P, et al. Bull Cancer. 2021 Dec;108(9S1):S22-S32. doi: 10.1016/S0007-4551(21)00584-1. Bull Cancer. 2021. PMID: 34955159 Review.

10

Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study.

Abe M, Shoji T, Chiba Y, Takatori E, Kaido Y, Nagasawa T, Kagabu M, Takahashi F, Aida T, Baba T. Abe M, et al. Anticancer Res. 2023 Mar;43(3):1265-1272. doi: 10.21873/anticanres.16273. Anticancer Res. 2023. PMID: 36854492

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

156 results

Results by year